$MGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MACROGENICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MACROGENICS INC. Get notifications about new insider transactions in MACROGENICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2019 | MGNX | MACROGENICS INC | Spitznagel Thomas | Sr VP, BPD & Manufa ... | Option Exercise | M | 7.51 | 1,770 | 13,293 | 62,147 | |
Feb 08 2019 | MGNX | MACROGENICS INC | Spitznagel Thomas | Sr VP, BPD & Manufa ... | Sell | S | 30.00 | 1,770 | 53,100 | 0 | 1.8 K to 0 (-100.00 %) |
Feb 08 2019 | MGNX | MACROGENICS INC | Spitznagel Thomas | Sr VP, BPD & Manufa ... | Buy | M | 7.51 | 1,770 | 13,293 | 1,770 | 0 to 1.8 K |
Jan 28 2019 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 6,000 | 5,640 | 2,497 | |
Jan 28 2019 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 6,000 | 5,640 | 28,309 | 22.3 K to 28.3 K (+26.89 %) |
Jan 28 2019 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 2,000 | 1,880 | 7,320 | |
Jan 28 2019 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 5,326 | 5,006 | 0 | |
Jan 28 2019 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 2,000 | 1,880 | 135,487 | 133.5 K to 135.5 K (+1.50 %) |
Jan 28 2019 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 5,326 | 5,006 | 133,487 | 128.2 K to 133.5 K (+4.16 %) |
Jan 10 2019 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 5,314 | 4,995 | 0 | |
Jan 10 2019 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 5,314 | 4,995 | 128,161 | 122.8 K to 128.2 K (+4.33 %) |
Dec 20 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 5,314 | |
Dec 20 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 5,000 | 4,700 | 122,847 | 117.8 K to 122.8 K (+4.24 %) |
Dec 13 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 4,497 | |
Dec 13 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 5,000 | 4,700 | 22,309 | 17.3 K to 22.3 K (+28.89 %) |
Nov 27 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 3,000 | 2,820 | 1,420 | |
Nov 27 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 3,000 | 2,820 | 117,847 | 114.8 K to 117.8 K (+2.61 %) |
Nov 27 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 3,000 | 2,820 | 1,420 | |
Nov 27 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 3,000 | 2,820 | 117,847 | 114.8 K to 117.8 K (+2.61 %) |
Oct 23 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 3,000 | 2,820 | 13,497 | |
Oct 23 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 3,000 | 2,820 | 12,100 | 9.1 K to 12.1 K (+32.97 %) |
May 21 2018 | MGNX | MACROGENICS INC | Galbraith Kenneth | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
May 21 2018 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
May 21 2018 | MGNX | MACROGENICS INC | SIEGEL JAY PHILIP | Director | Option Exercise | A | 2.34 | 10,000 | 23,400 | 10,000 | |
May 21 2018 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 21.34 | 6,293 | 134,293 | 6,293 | |
May 21 2018 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
May 21 2018 | MGNX | MACROGENICS INC | HURWITZ EDWARD | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
May 21 2018 | MGNX | MACROGENICS INC | STUMP DAVID C | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
May 21 2018 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
May 21 2018 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
Mar 14 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 1,000 | 940 | 20,497 | |
Mar 14 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Sell | S | 31.08 | 1,000 | 31,080 | 9,100 | 10.1 K to 9.1 K (-9.90 %) |
Mar 14 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 1,000 | 940 | 10,100 | 9.1 K to 10.1 K (+10.99 %) |
Mar 07 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Sell | S | 31.00 | 5,000 | 155,000 | 114,847 | 119.8 K to 114.8 K (-4.17 %) |
Mar 06 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | A | 28.94 | 70,000 | 2,025,800 | 70,000 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Peters Jeffrey Stuart | Acting General Coun ... | Option Exercise | A | 28.94 | 50,000 | 1,447,000 | 50,000 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | A | 28.94 | 70,000 | 2,025,800 | 70,000 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 4,000 | 3,760 | 21,497 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | A | 28.94 | 70,000 | 2,025,800 | 70,000 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Sell | S | 30.00 | 4,000 | 120,000 | 9,100 | 13.1 K to 9.1 K (-30.53 %) |
Mar 06 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 4,000 | 3,760 | 13,100 | 9.1 K to 13.1 K (+43.96 %) |
Mar 06 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | A | 28.94 | 70,000 | 2,025,800 | 70,000 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | A | 28.94 | 225,000 | 6,511,500 | 225,000 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Spitznagel Thomas | Sr VP, BPD & Manufa ... | Option Exercise | A | 28.94 | 50,000 | 1,447,000 | 50,000 | |
Mar 06 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | A | 28.94 | 28,000 | 810,320 | 28,000 | |
Mar 01 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 1,000 | 940 | 25,497 | |
Mar 01 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Sell | S | 25.01 | 1,000 | 25,005 | 9,100 | 10.1 K to 9.1 K (-9.90 %) |
Mar 01 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 1,000 | 940 | 10,100 | 9.1 K to 10.1 K (+10.99 %) |
Mar 01 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 1.51 | 7,989 | 12,063 | 0 | |
Mar 01 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 7,989 | 7,510 | 0 | |
Mar 01 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 7,989 | 7,510 | 0 | |
Mar 01 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 25.01 | 23,967 | 599,436 | 1,923 | 25.9 K to 1.9 K (-92.57 %) |
Mar 01 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 1.51 | 7,989 | 12,063 | 25,890 | 17.9 K to 25.9 K (+44.63 %) |
Mar 01 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 7,989 | 7,510 | 17,901 | 9.9 K to 17.9 K (+80.60 %) |
Mar 01 2018 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 7,989 | 7,510 | 9,912 | 1.9 K to 9.9 K (+415.44 %) |
Jan 25 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 3,000 | 2,820 | 26,497 | |
Jan 25 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Sell | S | 22.50 | 3,000 | 67,500 | 9,100 | 12.1 K to 9.1 K (-24.79 %) |
Jan 25 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 3,000 | 2,820 | 12,100 | 9.1 K to 12.1 K (+32.97 %) |
Jan 18 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 6,516 | 6,125 | 0 | |
Jan 18 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 6,516 | 6,125 | 119,847 | 113.3 K to 119.8 K (+5.75 %) |
Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 2,524 | 11,863 | 45,448 | |
Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 2,476 | 11,637 | 47,972 | |
Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 2,524 | 50,480 | 30,000 | 32.5 K to 30 K (-7.76 %) |
Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 2,524 | 11,863 | 32,524 | 30 K to 32.5 K (+8.41 %) |
Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 2,476 | 49,520 | 30,000 | 32.5 K to 30 K (-7.62 %) |
Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 2,476 | 11,637 | 32,476 | 30 K to 32.5 K (+8.25 %) |
Jan 18 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 2,000 | 1,880 | 29,497 | |
Jan 18 2018 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 2,000 | 1,880 | 9,100 | 7.1 K to 9.1 K (+28.17 %) |
Jan 03 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 3,000 | 2,820 | 6,516 | |
Jan 03 2018 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 3,000 | 2,820 | 113,331 | 110.3 K to 113.3 K (+2.72 %) |
Nov 21 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 5,000 | 23,500 | 50,448 | |
Nov 21 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 5,000 | 100,000 | 30,000 | 35 K to 30 K (-14.29 %) |
Nov 21 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 5,000 | 23,500 | 35,000 | 30 K to 35 K (+16.67 %) |
Nov 15 2017 | MGNX | MACROGENICS INC | SIEGEL JAY PHILIP | Director | Option Exercise | A | 17.85 | 20,000 | 357,000 | 20,000 | |
Oct 26 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 10,000 | 47,000 | 55,448 | |
Oct 26 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 10,000 | 200,000 | 30,000 | 40 K to 30 K (-25.00 %) |
Oct 26 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 10,000 | 47,000 | 40,000 | 30 K to 40 K (+33.33 %) |
Sep 07 2017 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 9,516 | |
Sep 07 2017 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 5,000 | 4,700 | 110,331 | 105.3 K to 110.3 K (+4.75 %) |
Sep 07 2017 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | M | 0.94 | 2,000 | 1,880 | 31,497 | |
Sep 07 2017 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Buy | M | 0.94 | 2,000 | 1,880 | 6,000 | 4 K to 6 K (+50.00 %) |
Jul 27 2017 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | M | 0.94 | 26,632 | 25,034 | 0 | |
Jul 27 2017 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | M | 1.51 | 26,632 | 40,214 | 0 | |
Jul 27 2017 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Buy | M | 0.94 | 26,632 | 25,034 | 146,658 | 120 K to 146.7 K (+22.19 %) |
Jul 27 2017 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Buy | M | 1.51 | 26,632 | 40,214 | 120,026 | 93.4 K to 120 K (+28.52 %) |
Jun 06 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 5,000 | 23,500 | 65,448 | |
Jun 06 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 5,000 | 100,000 | 30,000 | 35 K to 30 K (-14.29 %) |
Jun 06 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 5,000 | 23,500 | 35,000 | 30 K to 35 K (+16.67 %) |
May 22 2017 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
May 22 2017 | MGNX | MACROGENICS INC | STUMP DAVID C | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
May 22 2017 | MGNX | MACROGENICS INC | Galbraith Kenneth | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
May 22 2017 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
May 22 2017 | MGNX | MACROGENICS INC | HURWITZ EDWARD | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
May 22 2017 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 19.57 | 6,057 | 118,535 | 6,057 | |
May 22 2017 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
May 22 2017 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
May 02 2017 | MGNX | MACROGENICS INC | SARAN ATUL | SVP & General Couns ... | Payment of Exercise | F | 21.61 | 1,862 | 40,238 | 16,986 | 18.8 K to 17 K (-9.88 %) |
Apr 20 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 15,000 | 70,500 | 70,448 | |
Apr 20 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 15,000 | 300,000 | 30,000 | 45 K to 30 K (-33.33 %) |
Apr 20 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 15,000 | 70,500 | 45,000 | 30 K to 45 K (+50.00 %) |
Feb 16 2017 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | A | 20.53 | 28,000 | 574,840 | 28,000 | |
Feb 16 2017 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | A | 20.53 | 55,000 | 1,129,150 | 55,000 | |
Feb 16 2017 | MGNX | MACROGENICS INC | SARAN ATUL | SVP & General Couns ... | Option Exercise | A | 20.53 | 55,000 | 1,129,150 | 55,000 | |
Feb 16 2017 | MGNX | MACROGENICS INC | Spitznagel Thomas | Sr VP, BPD & Manufa ... | Option Exercise | A | 20.53 | 45,000 | 923,850 | 45,000 | |
Feb 16 2017 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | A | 20.53 | 55,000 | 1,129,150 | 55,000 | |
Feb 16 2017 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | A | 20.53 | 67,500 | 1,385,775 | 67,500 | |
Feb 16 2017 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | A | 20.53 | 200,000 | 4,106,000 | 200,000 | |
Feb 16 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | A | 20.53 | 67,500 | 1,385,775 | 67,500 | |
Jan 26 2017 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 14,516 | |
Jan 26 2017 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 5,000 | 4,700 | 105,331 | 100.3 K to 105.3 K (+4.98 %) |
Jan 25 2017 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 18.52 | 20,000 | 370,400 | 20,000 | |
Jan 25 2017 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 18.52 | 20,000 | 370,400 | 20,000 | |
Jan 19 2017 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | M | 0.94 | 79,898 | 75,104 | 0 | |
Jan 19 2017 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Buy | M | 0.94 | 79,898 | 75,104 | 133,163 | 53.3 K to 133.2 K (+150.00 %) |
Oct 21 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | M | 0.94 | 5,349 | 5,028 | 0 | |
Oct 21 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | M | 0.94 | 1,309 | 1,230 | 5,349 | |
Oct 21 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | M | 0.94 | 10,653 | 10,014 | 0 | |
Oct 21 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Buy | M | 0.94 | 5,349 | 5,028 | 100,944 | 95.6 K to 100.9 K (+5.60 %) |
Oct 21 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Buy | M | 0.94 | 11,962 | 11,244 | 95,595 | 83.6 K to 95.6 K (+14.30 %) |
Oct 05 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 10,000 | 47,000 | 15,254 | |
Oct 05 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 29.34 | 10,000 | 293,400 | 0 | 10 K to 0 (-100.00 %) |
Oct 05 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 10,000 | 47,000 | 10,000 | 0 to 10 K |
Oct 05 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 3,994 | 3,754 | 0 | |
Oct 05 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 2,237 | 2,103 | 0 | |
Oct 05 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 29.28 | 6,231 | 182,444 | 1,923 | 8.2 K to 1.9 K (-76.42 %) |
Oct 05 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 6,231 | 5,857 | 8,154 | 1.9 K to 8.2 K (+324.02 %) |
Sep 16 2016 | MGNX | MACROGENICS INC | Spitznagel Thomas | Sr VP, BPD & Manufa ... | Option Exercise | A | 28.94 | 20,000 | 578,800 | 20,000 | |
Sep 16 2016 | MGNX | MACROGENICS INC | Risser Eric Blasius | Sr VP & Chief Busin ... | Option Exercise | A | 28.94 | 25,000 | 723,500 | 25,000 | |
Sep 16 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Sr VP, Research & C ... | Option Exercise | A | 28.94 | 30,000 | 868,200 | 30,000 | |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 20,000 | 94,000 | 35,254 | |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 20,000 | 94,000 | 35,254 | |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 20,000 | 94,000 | 35,254 | |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 30.78 | 20,000 | 615,600 | 0 | 20 K to 0 (-100.00 %) |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 30.78 | 20,000 | 615,600 | 0 | 20 K to 0 (-100.00 %) |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 30.78 | 20,000 | 615,600 | 0 | 20 K to 0 (-100.00 %) |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 20,000 | 94,000 | 20,000 | 0 to 20 K |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 20,000 | 94,000 | 20,000 | 0 to 20 K |
Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 20,000 | 94,000 | 20,000 | 0 to 20 K |
Jul 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 5,000 | 23,500 | 55,254 | |
Jul 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 27.22 | 5,000 | 136,100 | 0 | 5 K to 0 (-100.00 %) |
Jul 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
Jul 06 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 4,421 | 4,156 | 7,989 | |
Jul 06 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 4,501 | 4,231 | 7,989 | |
Jul 06 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 27.22 | 8,922 | 242,857 | 1,923 | 10.8 K to 1.9 K (-82.27 %) |
Jul 06 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 8,922 | 8,387 | 10,845 | 1.9 K to 10.8 K (+463.96 %) |
May 27 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 4,501 | |
May 27 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 25.00 | 5,000 | 125,000 | 1,923 | 6.9 K to 1.9 K (-72.22 %) |
May 27 2016 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 5,000 | 4,700 | 6,923 | 1.9 K to 6.9 K (+260.01 %) |
May 20 2016 | MGNX | MACROGENICS INC | Galbraith Kenneth | Director | Option Exercise | A | 21.06 | 8,500 | 179,010 | 8,500 | |
May 20 2016 | MGNX | MACROGENICS INC | HURWITZ EDWARD | Director | Option Exercise | A | 21.06 | 8,500 | 179,010 | 8,500 |